Skip to main content

Trump announces lower prices, Medicare coverage for popular weight-loss drugs

Healthcare,Medicare,Drugs,Weight Loss,Obesity And Malnutrition,Drug Prices

From the Left

President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications for older adults.

The negotiated deals will allow Medicare and Medicaid coverage for Lilly's Zepbound and Novo's Wegovy, and consumers will be able to purchase drugs at discounted prices through the federal government's direct-to-consumer website, TrumpRx, which will launch in 2026...

AllSides Picks

More News about Healthcare

News from the Left

News from the Center

News from the Right